Articles

Effects of routine early treatment with PCSK9 inhibitors in patients undergoing primary percutaneous coronary intervention for ST-segment elevation myocardial infarction: a randomised, double-blind, sham-controlled trial

Mehta SR, Pare G, Lonn EM, et al.

Journal: 

EuroIntervention

First published: December 2, 2022  DOI: 10.4244/EIJ-D-22-00735

Abstract


Full Article